Elp1 study reveals a regulator of immune-cell formation for experimental brain repopulation
Published in Biology, Brain/Neurology, Immunology, Journals.
Published October 15, 2026.
A Nature study published on October 14 identifies Elp1 as an important regulator of the formation of myeloid immune cells in experimental models relevant to brain cell replacement. Marius Marc-Daniel Mader, Wanhua Li and colleagues developed a platform using blood-forming stem and progenitor cells expanded outside the body.
The cultured cells could be genetically modified, differentiate into myeloid cells and populate the brain’s microglial niches after transplantation in experimental models. Signals from neonatal astrocytes also promoted myeloid differentiation in laboratory cultures.
By screening approximately 20,000 genetic perturbations, the researchers identified regulators of this process. Elp1 helped suppress the unfolded protein response during differentiation and was required for generating myeloid cells, but not for maintaining them once formed.
The work provides a research platform for understanding how donor-derived immune cells develop in the brain. It does not demonstrate an effective treatment for a neurological disease in patients; translating these mechanisms into safe cell therapies requires further investigation.